Jpmorgan Chase & CO Biolife Solutions Inc Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
A detailed history of Jpmorgan Chase & CO transactions in Biolife Solutions Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 285,735 shares of BLFS stock, worth $7.3 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
285,735
Previous 334,948
14.69%
Holding current value
$7.3 Million
Previous $6.21 Million
1.45%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding BLFS
# of Institutions
180Shares Held
46.2MCall Options Held
11.6KPut Options Held
800-
Casdin Capital, LLC New York, NY8.71MShares$223 Million16.09% of portfolio
-
Black Rock Inc. New York, NY5.49MShares$140 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA3.32MShares$84.9 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.79MShares$71.2 Million0.0% of portfolio
-
Fred Alger Management, LLC New York, NY1.58MShares$40.4 Million0.17% of portfolio
About BIOLIFE SOLUTIONS INC
- Ticker BLFS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 42,684,400
- Market Cap $1.09B
- Description
- BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...